Stock CLCS CELL SOURCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cell Source, Inc.

Equities

CLCS

US15114L1044

Delayed OTC Markets
Other stock markets
 10:24:58 09/05/2024 pm IST 		5-day change 1st Jan Change
0.0008 USD +300.00% Intraday chart for Cell Source, Inc. -.--% -99.83%
22/03 Cell Source, Inc. announced that it has received $4.76017 million in funding CI
2023 Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CELL SOURCE, INC. Stock Cell Source, Inc.
 32.82T - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 12TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
BIONTECH SE Stock BioNTech SE
 2.48TCr -
ARGENX SE Stock argenx SE
 2.25TCr -
GENMAB A/S Stock Genmab A/S
 1.83TCr
  1. Stock Market
  2. Equities
  3. CLCS Stock
  4. Charts Cell Source, Inc.
  5. Sector Chart